Sangamo Therapeutics, Inc. (SGMOQ)
OTCMKTS · Delayed Price · Currency is USD
0.14778
+0.00768 (5.48%)
At close: Oct 9, 2026
Sangamo Therapeutics Market Cap
Sangamo Therapeutics has a market cap or net worth of $61.22 million as of October 9, 2026. It is the 28,989th most valuable company in the world and the 4,516th biggest in the United States. Its market cap has decreased by 70.66% in one year.
Market Cap
61.22M
Enterprise Value
52.97M
Revenue
34.56M
Global Rank
Country Rank
#4,516 United States
PE Ratio
n/a
ChartMarket Cap Chart
Since April 6, 2000, Sangamo Therapeutics's market cap has decreased from 92.36M to 61.22M, a decrease of -33.71%. That is a compound annual growth rate of -1.54%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 9, 2026 | 61.22M | -56.68% |
| Dec 31, 2025 | 141.33M | -33.59% |
| Dec 31, 2024 | 212.82M | 120.88% |
| Dec 29, 2023 | 96.35M | -81.28% |
| Dec 30, 2022 | 514.58M | -52.90% |
| Dec 31, 2021 | 1.09B | -50.50% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| BetterLife Pharma | 117.42M |
| Vaxart | 104.94M |
| HST Global | 99.00M |
| NDT Pharmaceuticals | 66.87M |
| Nuo Therapeutics | 62.96M |
| ProText Mobility | 60.66M |
| Arch Biopartners | 39.33M |
| Cell Source | 37.55M |